<?xml version="1.0" encoding="UTF-8"?>
<xml><bibliography><APA>Surasak Chaiyasong. (2013) Outcome and Cost of Colistin and Tigecycline for Treatment of Gram-Negative Infections. &lt;i&gt;Isan Journal ofPharmaceutical Sciences&lt;/i&gt;, &lt;i&gt;9&lt;/i&gt;(3), 65-73.</APA><Chicago>Surasak Chaiyasong. "Outcome and Cost of Colistin and Tigecycline for Treatment of Gram-Negative Infections". Isan Journal ofPharmaceutical Sciences  9 (2013):65-73.</Chicago><MLA>Surasak Chaiyasong. Outcome and Cost of Colistin and Tigecycline for Treatment of Gram-Negative Infections. Faculty of Pharmaceutical Sciences KKU MSU UBU:ม.ป.ท. 2013.</MLA></bibliography></xml>
